Cargando…

State Medicaid Pharmacy Payments and Their Relation to Estimated Costs

Although prescription drugs do not appear to be a primary source of recent surges in Medicaid spending, their share of Medicaid expenditures has risen despite efforts to control costs. As part of a general concern with prescription drug policy, Congress mandated a study of the adequacy of Medicaid p...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, E. Kathleen, Kreling, David H., Gondek, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CENTERS for MEDICARE & MEDICAID SERVICES 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193454/
https://www.ncbi.nlm.nih.gov/pubmed/10137796
_version_ 1782338978574237696
author Adams, E. Kathleen
Kreling, David H.
Gondek, Kathleen
author_facet Adams, E. Kathleen
Kreling, David H.
Gondek, Kathleen
author_sort Adams, E. Kathleen
collection PubMed
description Although prescription drugs do not appear to be a primary source of recent surges in Medicaid spending, their share of Medicaid expenditures has risen despite efforts to control costs. As part of a general concern with prescription drug policy, Congress mandated a study of the adequacy of Medicaid payments to pharmacies. In this study, several data sources were used to develop 1991 estimates of average pharmacy ingredient and dispensing costs. A simulation was used to estimate the amounts States pay. Nationally, simulated payments averaged 96 percent of estimated costs overall but were lower for dispensing costs (79 percent) and higher for ingredient costs (102 percent).
format Online
Article
Text
id pubmed-4193454
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher CENTERS for MEDICARE & MEDICAID SERVICES
record_format MEDLINE/PubMed
spelling pubmed-41934542014-11-04 State Medicaid Pharmacy Payments and Their Relation to Estimated Costs Adams, E. Kathleen Kreling, David H. Gondek, Kathleen Health Care Financ Rev Prescription Drugs: Payment and Policy Issues Although prescription drugs do not appear to be a primary source of recent surges in Medicaid spending, their share of Medicaid expenditures has risen despite efforts to control costs. As part of a general concern with prescription drug policy, Congress mandated a study of the adequacy of Medicaid payments to pharmacies. In this study, several data sources were used to develop 1991 estimates of average pharmacy ingredient and dispensing costs. A simulation was used to estimate the amounts States pay. Nationally, simulated payments averaged 96 percent of estimated costs overall but were lower for dispensing costs (79 percent) and higher for ingredient costs (102 percent). CENTERS for MEDICARE & MEDICAID SERVICES 1994 /pmc/articles/PMC4193454/ /pubmed/10137796 Text en
spellingShingle Prescription Drugs: Payment and Policy Issues
Adams, E. Kathleen
Kreling, David H.
Gondek, Kathleen
State Medicaid Pharmacy Payments and Their Relation to Estimated Costs
title State Medicaid Pharmacy Payments and Their Relation to Estimated Costs
title_full State Medicaid Pharmacy Payments and Their Relation to Estimated Costs
title_fullStr State Medicaid Pharmacy Payments and Their Relation to Estimated Costs
title_full_unstemmed State Medicaid Pharmacy Payments and Their Relation to Estimated Costs
title_short State Medicaid Pharmacy Payments and Their Relation to Estimated Costs
title_sort state medicaid pharmacy payments and their relation to estimated costs
topic Prescription Drugs: Payment and Policy Issues
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193454/
https://www.ncbi.nlm.nih.gov/pubmed/10137796
work_keys_str_mv AT adamsekathleen statemedicaidpharmacypaymentsandtheirrelationtoestimatedcosts
AT krelingdavidh statemedicaidpharmacypaymentsandtheirrelationtoestimatedcosts
AT gondekkathleen statemedicaidpharmacypaymentsandtheirrelationtoestimatedcosts